Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M182,412Revenue (TTM) $M39,807Net Margin (%)14.3Altman Z-Score--
Enterprise Value $M182,412EPS (TTM) $2.0Operating Margin %22.5Piotroski F-Score--
P/E(ttm)33.1Beneish M-Score--Pre-tax Margin (%)18.8Higher ROA y-yN
Price/Book4.310-y EBITDA Growth Rate %-9.2Quick Ratio--Cash flow > EarningsN
Price/Sales4.75-y EBITDA Growth Rate %-30.0Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow33.3y-y EBITDA Growth Rate %-91.8ROA % (ttm)5.8Higher Current Ratio y-yN
Dividend Yield %2.8PEG--ROE % (ttm)12.9Less Shares Outstanding y-yN
Payout Ratio %94.0Shares Outstanding M2,757ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

MRK is held by these investors:

MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Karachun Rita ASr. VP Fince-Global Controller 2017-02-14Sell2,954$64.732.07view
RUSSO PATRICIA FDirector 2017-02-08Sell5,000$64.422.56view
WEEKS WENDELL PDirector 2017-02-06Sell5,000$64.512.42view
WENDELL PETER CDirector 2017-02-03Sell15,000$63.693.74view
Holston Michael JEVP, General Counsel 2017-02-03Sell91,959$63.963.3view
Schechter Adam HEVP & Pres-Global Human Health 2017-02-03Sell36,335$63.733.67view
Cech Thomas RDirector 2017-02-03Sell5,000$63.424.18view
FRAZIER KENNETH CChairman, President & CEO 2016-11-10Sell140,000$65.031.6view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2016-11-07Sell85,523$60.0210.08view
LAZARUS ROCHELLE BDirector 2016-11-02Sell20,000$59.0611.87view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
Why 3D Printing and Biotech Will Be Good Bets in 2017 Feb 23 2017 
Dow Jones Closes at 20,504.41 Feb 15 2017 
Nasdaq Reaches a New High on Wednesday Feb 08 2017 
Merck: Analyzing 2016 Performance and Outlook for 2017 Feb 04 2017 
Is Bristol-Meyers a Buy After 39% Price Decline? Jan 29 2017 
US Market Indexes Lower on Monday Jan 24 2017 
US Market Indexes Lower for the Week Jan 21 2017 
US Market Indexes Higher After Trump Press Conference Jan 11 2017 
US Market Indexes Trade Flat Jan 10 2017 
Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 

More From Other Websites
In First Phase 3 Trial, Merck’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212)... Feb 24 2017
Merck Antiviral Drug Reports Positive Data Feb 24 2017
Eli Lilly & Co.’s Cardiovascular Franchise Feb 24 2017
Wall Street Analysts’ Estimates for Merck & Co. Feb 24 2017
Merck & Co.’s Profit Margins for 4Q16 Feb 24 2017
Only 1 of 30 Dow stocks is trading higher premarket Feb 24 2017
Merck Receives Positive CHMP Opinion for New Pergoveris® Fertility Pen Feb 24 2017
Merck & Co.’s Animal Health Segment Feb 24 2017
Exclusive - Trump says Republican border tax could boost U.S. jobs Feb 23 2017
Merck to take $2.9 billion charge on hepatitis C drug Feb 23 2017
Eli Lilly & Co.’s Revenues in 4Q16 Feb 23 2017
MERCK & CO., INC. Files SEC form 8-K, Material Impairments Feb 23 2017
Doubts persist about tax timing as Trump meets with CEOs Feb 23 2017
Merck drug prevents serious infection after marrow transplant -study Feb 23 2017
Remicade: Driving Down Merck & Co.’s Immunology Franchise Feb 23 2017
Januvia and Janumet: Merck & Co.’s Blockbuster Diabetes Products Feb 23 2017
Gardasil Driving Merck & Co.’s Vaccines Business in 4Q16 Feb 23 2017
Why Do Stocks' Fair Value Estimates Change? Feb 23 2017
Cramer: Buyers for Bristol-Myers Are Few and Far Between Feb 22 2017
Bristol Myers' Future Unsure as Carl Icahn Takes Stake Feb 22 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)